| Genomic analyses identify molecular subtypes of pancreatic cancer P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ... Nature 531 (7592), 47-52, 2016 | 3134 | 2016 |
| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1501 | 2020 |
| Helicobacter pylori infection and chronic gastric acid hyposecretion EM El-Omar, K Oien, A El-Nujumi, D Gillen, A Wirz, S Dahill, C Williams, ... Gastroenterology 113 (1), 15-24, 1997 | 779 | 1997 |
| Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer JP Morton, P Timpson, SA Karim, RA Ridgway, D Athineos, B Doyle, ... Proceedings of the National Academy of Sciences 107 (1), 246-251, 2010 | 731 | 2010 |
| Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori EM El–Omar, K Oien, LS Murray, A El–Nujumi, A Wirz, D Gillen, ... Gastroenterology 118 (1), 22-30, 2000 | 423 | 2000 |
| Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm JL Dennis, TR Hvidsten, EC Wit, J Komorowski, AK Bell, I Downie, ... Clinical Cancer Research 11 (10), 3766-3772, 2005 | 404 | 2005 |
| Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up K Fizazi, FA Greco, N Pavlidis, G Daugaard, K Oien, G Pentheroudakis Annals of Oncology 26, v133-v138, 2015 | 347 | 2015 |
| Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis S Hagan, F Al-Mulla, E Mallon, K Oien, R Ferrier, B Gusterson, ... Clinical Cancer Research 11 (20), 7392-7397, 2005 | 333 | 2005 |
| Co-amoxiclav jaundice: clinical and histological features and HLA class II association J O'donohue, KA Oien, P Donaldson, J Underhill, M Clare, ... Gut 47 (5), 717-720, 2000 | 270 | 2000 |
| Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy BW Miller, JP Morton, M Pinese, G Saturno, NB Jamieson, E McGhee, ... EMBO molecular medicine 7 (8), 1063-1076, 2015 | 267 | 2015 |
| MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma NB Jamieson, DC Morran, JP Morton, A Ali, EJ Dickson, CR Carter, ... Clinical Cancer Research 18 (2), 534-545, 2012 | 246 | 2012 |
| Pathologic evaluation of unknown primary cancer KA Oien Seminars in oncology 36 (1), 8-37, 2009 | 241 | 2009 |
| Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma NB Jamieson, AK Foulis, KA Oien, JJ Going, P Glen, EJ Dickson, ... Annals of surgery 251 (6), 1003-1010, 2010 | 240 | 2010 |
| Loss of Apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo OJ Sansom, V Meniel, JA Wilkins, AM Cole, KA Oien, V Marsh, ... Proceedings of the National Academy of Sciences 103 (38), 14122-14127, 2006 | 236 | 2006 |
| Activation of the PIK3CA/AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis AL Kennedy, JP Morton, I Manoharan, DM Nelson, NB Jamieson, ... Molecular cell 42 (1), 36-49, 2011 | 226 | 2011 |
| Hypermutation in pancreatic cancer JL Humphris, AM Patch, K Nones, PJ Bailey, AL Johns, S McKay, ... Gastroenterology 152 (1), 68-74. e2, 2017 | 211 | 2017 |
| Artificial intelligence in digital pathology: a roadmap to routine use in clinical practice R Colling, H Pitman, K Oien, N Rajpoot, P Macklin, ... The Journal of pathology 249 (2), 143-150, 2019 | 196 | 2019 |
| Hepatic granulomas: a 10 year single centre experience DR Gaya, D Thorburn, KA Oien, AJ Morris, AJ Stanley Journal of clinical pathology 56 (11), 850-853, 2003 | 192 | 2003 |
| N-WASP coordinates the delivery and F-actin–mediated capture of MT1-MMP at invasive pseudopods X Yu, T Zech, L McDonald, EG Gonzalez, A Li, I Macpherson, JP Schwarz, ... Journal of cell biology 199 (3), 527-544, 2012 | 190 | 2012 |
| Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer CSD Roxburgh, JM Salmond, PG Horgan, KA Oien, DC McMillan Annals of surgery 249 (5), 788-793, 2009 | 186 | 2009 |
Nigel B JamiesonProfessor of Surgery and Consultant HPB Surgeon, Glasgow UniversityVerified email at glasgow.ac.uk
